About Edward Lahey, MD, DMD

Dr. Edward Lahey hails from Connecticut, where he received his undergraduate degree from Fairfield University. He received his DMD summa cum laude from Tufts University School of Dental Medicine and then completed the year-long Clinical Research Training Program at the National Institutes of Health in Bethesda, Maryland. Dr. Lahey obtained his MD from Harvard Medical School while completing his residency in oral and maxillofacial surgery at Massachusetts General Hospital.

Dr. Lahey is a diplomate of the American Board of Oral and Maxillofacial Surgery. He is an attending in oral and maxillofacial surgery at Mass General and Instructor of Oral and Maxillofacial Surgery at HSDM.  His research-oriented practice focuses on the surgical treatment of adult and pediatric jaw abnormalities, wisdom teeth, dental implants, maxillofacial trauma, and pathology.

Clinical Interests:



Oral and Maxillofacial Surgery
15 Parkman Street
Boston, MA 02114-3117
Phone: 617-726-2740
Fax: 617-726-6195

Medical Education

  • MD, Harvard Medical School
  • DMD, Tufts School of Dental Medicine
  • Residency, Massachusetts General Hospital

American Board Certifications

  • Oral & Maxillofacial Surgery, American Board of Oral and Maxillofacial Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • Select Publications:

    • Susarla SM, Sharaf BA, Faquin W, Hasserjian RP, McDermott N, Lahey E. Extranodal natural killer T-cell lymphoma, nasal type, with minimal osseous involvement: report of a case and literature review.J Oral Maxillofac Surg. 2010 Mar;68(3):674-81.
    • Leon F, Contractor N, Fuss I, Marth T, Lahey E, Iwaki S, la Sala A, Hoffmann V, Strober W, Kelsall BL. Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J Immunol. 2006 Nov 15;177(10):6974-82. 
    • Braun MC, Wang JM, Lahey E, Rabin RL, Kelsall BL. Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes. 2001 Jun 1;97(11):3531-6. 
    • Braun MC, Lahey E, Kelsall BL. Selective suppression of IL-12 production by chemoattractants. J Immunol. 2000 Mar 15;164(6):3009-17.

    Dr. Lahey's Harvard Catalyst page